NASDAQ$HSTM

HealthStream Inc · Q1 2020 earnings

Q1 2020 earnings · · Investor relations

Briefing

HealthStream's first quarter results were announced, showing a mix of growth and challenges.

HealthStream reported a decrease in revenue by 6% compared to Q1 2019, but operating income increased by 35% due to a favorable contractual adjustment. The company completed the acquisition of NurseGrid for $25 million and authorized a share repurchase program of up to $30 million.

  • Revenues decreased by 6% to $61.6 million compared to $65.2 million in Q1 2019.
  • Operating income increased by 35% to $7.2 million, up from $5.4 million in Q1 2019, positively impacted by a $3.4 million contractual adjustment.
  • Earnings per share (EPS) from continuing operations was $0.22, compared to $0.15 per share in Q1 2019.
  • Adjusted EBITDA from continuing operations decreased by 6% to $11.8 million from $12.5 million in Q1 2019.

Headline financials

Total Revenue

$61.6M

Previous: $65.2M-5.5%
EPS (adj)

$0.14

Previous: $0.15-6.7%
Capital Expenditures

-$1.01M

Previous: -$11.3M+91.1%
Free Cash Flow

$6.08M

Previous: -$5.36M+213.4%
Net Income

$7.09M

Previous: $5.97M+18.7%
Operating Income

$7.24M

Previous: $5.37M+34.9%
Gross Profit

-$20.4M

Previous: $38.3M-153.1%
Cash & Equivalents

$107M

Previous: $111M-2.9%
Total Assets

$482M

Previous: $484M-0.4%
Stock-Based Comp

$550K

Previous: $516K+6.6%

Revenue & EPS history

HealthStream · Revenue · Quarterly

$61.6M

Q1 2020-5.5%vs Q1 2019
Beat estimate in 16 of 16 quarters(100%)
ActualEstimate

Revenue by segment

HealthStream · $3.1M total across 2 segments · Q3 2023

  • Subscription Revenues
    $3.4M
  • Professional Services
    -$300K

Forward guidance

Due to the unpredictable and rapidly evolving environment related to the COVID-19 pandemic, the Company cannot reasonably quantify the impact that the pandemic will have on its operating and financial results in 2020, and is withdrawing its 2020 guidance.

Tailwinds

  • The Company expects to continue providing its full range of workforce and provider solutions to its customers.
  • The Company expects to continue supporting all healthcare providers in their efforts to overcome the COVID-19 pandemic.

Headwinds

  • The extent of COVID-19’s negative impact on its operating results and financial condition will be driven by many factors.
  • Factors include the length and severity of the COVID-19 pandemic and the impact of the pandemic on economic activity, particularly with respect to healthcare organizations.
  • Business and economic conditions resulting from the pandemic.
  • The impact on the pandemic on healthcare organizations.
  • Potential workforce disruptions and the disruption in capital and financial markets.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q1 2020

Historical avgQ1 2020

+0.4%

Avg return

Earnings day

-1.3%

Avg return

5 days after

-0.3%

Avg return

30 days after

49%

32 / 65 earnings

Positive

+22.1%

Q3 2014

Best reaction

-19.3%

Q1 2025

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-5.0%-5.2%+3.6%
Q4 2025+5.7%-0.0%+0.0%
Q3 2025+2.8%-2.6%-2.4%
Q1 2025-19.3%-16.2%-14.9%
Q4 2024+0.1%+4.4%-0.8%
Q3 2024+4.3%-1.8%+8.5%
Q2 2024-3.0%-3.4%-7.3%
Q1 2024+6.3%+3.1%+9.8%
Q4 2023-1.6%-2.8%-2.8%
Q3 2023+13.6%+11.0%+16.0%
Q2 2023-1.4%-3.7%-8.1%
Q1 2023-6.9%-9.5%-12.3%
Q4 2022+4.9%+3.1%+7.0%
Q3 2022+4.6%+11.3%+14.3%
Q2 2022+4.5%+2.1%-2.0%
Q1 2022+2.2%-1.6%+4.4%
Q4 2021-17.0%-16.7%-14.7%
Q3 2021-8.8%-6.0%-10.9%
Q2 2021+0.6%-0.8%+0.2%
Q1 2021+9.2%+8.0%+18.4%
Q4 2020+0.7%+0.5%-2.6%
Q3 2020-9.4%-14.2%-9.3%
Q2 2020+0.3%+1.1%-5.6%
Q1 2020-3.4%-9.7%-4.1%
Q4 2019+0.2%+1.4%-16.1%
Q3 2019+6.3%+7.0%+4.4%
Q2 2019-0.8%+3.4%+3.5%
Q1 2019-4.8%-3.0%-5.0%
Q4 2018+3.9%+1.5%+5.8%
Q3 2018+1.8%-5.3%-15.2%
Q2 2018-6.5%-4.2%+6.2%
Q1 2018+4.8%+9.7%+17.3%
Q4 2017+6.0%+2.0%+1.9%
Q3 2017-0.3%-2.7%+2.6%
Q2 2017-12.0%-12.6%-13.5%
Q1 2017+17.3%+17.3%+18.2%
Q4 2016+0.1%+5.0%-2.8%
Q3 2016-9.5%-15.6%-2.3%
Q2 2016-3.9%-6.2%+0.1%
Q1 2016-0.8%
Q4 2015+12.9%
Q3 2015+10.8%
Q2 2015-0.6%
Q1 2015+12.1%
Q4 2014-7.9%
Q3 2014+22.1%
Q2 2014+13.9%
Q1 2014-5.7%
Q4 2013-7.2%
Q3 2013-4.5%
Q2 2013+11.2%
Q1 2013+16.9%
Q4 2012-0.2%
Q3 2012+1.9%
Q2 2012-2.9%
Q1 2011-2.1%
Q1 2012+2.0%
Q4 2009-5.1%
Q4 2011-5.1%
Q3 2010-5.8%
Q3 2011-5.8%
Q2 2011-4.4%
Q2 2010-4.4%
Q4 2010-4.4%
Q1 2010+5.6%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro